Your browser doesn't support javascript.
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
Bouazza, B; Ramdani, I; Chahed, R.
  • Bouazza B; Biochemistry and Microbiology Department, Mouloud Mammeri University of Tizi-Ouzou, Algeria.
  • Ramdani I; Biochemistry and Microbiology Department, Mouloud Mammeri University of Tizi-Ouzou, Algeria.
  • Chahed R; Cabinet Médical Privé, Spécialité de Pneumologie, Tizi-Ouzou, Algeria.
New Microbes New Infect ; 40: 100843, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1046192
ABSTRACT
COVID-19 is a world public health emergency caused by the new coronavirus, SARSCoV-2. Many drugs were repurposed as a treatment for COVID-19 patients including Chloroquine (CQ). CQ is a bitter taste receptor agonist reported to relax the airways suggesting a role in preventing disease severity of COVID-19 patients with asthma.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: New Microbes New Infect Year: 2021 Document Type: Article Affiliation country: J.nmni.2021.100843

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: New Microbes New Infect Year: 2021 Document Type: Article Affiliation country: J.nmni.2021.100843